A G Minko, T A Danilova, V G Lunin, M S Gromova, G A Danilina, A A Adzhieva, V G Zhukhovitsky
{"title":"The Effect of Streptococcal Pyrogenic Exotoxin Type A (SpeA) on the Formation of Streptococcus pyogenes Biofilm.","authors":"A G Minko, T A Danilova, V G Lunin, M S Gromova, G A Danilina, A A Adzhieva, V G Zhukhovitsky","doi":"10.1007/s10517-026-06686-x","DOIUrl":null,"url":null,"abstract":"<p><p>The effect of recombinant streptococcal (Streptococcus pyogenes) exotoxin type A (rSpeA) on biofilm formation by S. pyogenes was studied using a laboratory strain of serotype M30 and five non-typeable clinical strains of S. pyogenes. The inhibition of bacterial growth was observed during both the initial formation stage and within established biofilms. It was shown that under the action of rSpeA on biofilm formation, the growth of strain M30 was inhibited by 1.6 times and the growth of strains 1, 2, and 3 was inhibited by 2.3, 1.3, and 1.4 times, respectively. For strains 4 and 5, the inhibition was practically absent. Application of SpeA to the formed biofilm of streptococcal strains produced a more pronounced inhibitory effect: 2.5-fold for strain M30, and 5.5-, 3.4-, and 4.2-fold for strains No. 2, 3, and 5, respectively. These findings suggest that SpeA being a superantigen can also destroy streptococcal biofilms promoting the spread of bacteria in the body and leading to generalization of the infectious process.</p>","PeriodicalId":9331,"journal":{"name":"Bulletin of Experimental Biology and Medicine","volume":" ","pages":"614-617"},"PeriodicalIF":0.7000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of Experimental Biology and Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10517-026-06686-x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/2 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
The effect of recombinant streptococcal (Streptococcus pyogenes) exotoxin type A (rSpeA) on biofilm formation by S. pyogenes was studied using a laboratory strain of serotype M30 and five non-typeable clinical strains of S. pyogenes. The inhibition of bacterial growth was observed during both the initial formation stage and within established biofilms. It was shown that under the action of rSpeA on biofilm formation, the growth of strain M30 was inhibited by 1.6 times and the growth of strains 1, 2, and 3 was inhibited by 2.3, 1.3, and 1.4 times, respectively. For strains 4 and 5, the inhibition was practically absent. Application of SpeA to the formed biofilm of streptococcal strains produced a more pronounced inhibitory effect: 2.5-fold for strain M30, and 5.5-, 3.4-, and 4.2-fold for strains No. 2, 3, and 5, respectively. These findings suggest that SpeA being a superantigen can also destroy streptococcal biofilms promoting the spread of bacteria in the body and leading to generalization of the infectious process.
期刊介绍:
Bulletin of Experimental Biology and Medicine presents original peer reviewed research papers and brief reports on priority new research results in physiology, biochemistry, biophysics, pharmacology, immunology, microbiology, genetics, oncology, etc. Novel trends in science are covered in new sections of the journal - Biogerontology and Human Ecology - that first appeared in 2005.
World scientific interest in stem cells prompted inclusion into Bulletin of Experimental Biology and Medicine a quarterly scientific journal Cell Technologies in Biology and Medicine (a new Russian Academy of Medical Sciences publication since 2005). It publishes only original papers from the leading research institutions on molecular biology of stem and progenitor cells, stem cell as the basis of gene therapy, molecular language of cell-to-cell communication, cytokines, chemokines, growth and other factors, pilot projects on clinical use of stem and progenitor cells.
The Russian Volume Year is published in English from April.